Skip to content
10-Q

Quarterly Report

BLACK DIAMOND THERAPEUTICS, INC. BDTX

0001701541-24-000042

← back to feed
Filed
Nov 5, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Oct 31, 2024 56.59M sh
Capex Q3 2024 · Sep 30, 2024 $0
Capex Q3 2024 · Sep 30, 2023 $33K
Current Liabilities Q3 2024 · Sep 30, 2024 $20.8M
Current Liabilities Q3 2024 · Dec 31, 2023 $19.65M
Total Liabilities Q3 2024 · Sep 30, 2024 $40.47M
Total Liabilities Q3 2024 · Dec 31, 2023 $41.83M
Current Assets Q3 2024 · Sep 30, 2024 $115.54M
Current Assets Q3 2024 · Dec 31, 2023 $134.03M
Total Assets Q3 2024 · Sep 30, 2024 $137.9M
Total Assets Q3 2024 · Dec 31, 2023 $158.57M
Cash And Equivalents Q3 2024 · Dec 31, 2023 $56.22M
Cash And Equivalents Q3 2024 · Sep 30, 2023 $57.98M
Shares Diluted Q3 2024 · Sep 30, 2023 50.94M sh
Shares Diluted Q3 2024 · Sep 30, 2023 41.37M sh
Operating Cash Flow Q3 2024 · Sep 30, 2023 −$52.76M
Stockholders Equity Q3 2024 · Sep 30, 2023 $134.32M
Stockholders Equity Q3 2024 · Jun 30, 2023 $82.2M
Stockholders Equity Q3 2024 · Mar 31, 2023 $98.19M
Stockholders Equity Q3 2024 · Dec 31, 2022 $115.7M
Eps Diluted Q3 2024 · Sep 30, 2023 −$0.45
Eps Diluted Q3 2024 · Sep 30, 2023 −$1.54
Eps Basic Q3 2024 · Sep 30, 2023 −$0.45
Eps Basic Q3 2024 · Sep 30, 2023 −$1.54
Sga Expense Q3 2024 · Sep 30, 2023 $7.86M
Sga Expense Q3 2024 · Sep 30, 2023 $21.54M
Rd Expense Q3 2024 · Sep 30, 2023 $16.15M
Rd Expense Q3 2024 · Sep 30, 2023 $44.06M
Net Income Q3 2024 · Sep 30, 2023 −$23.01M
Net Income Q3 2024 · Sep 30, 2023 −$63.03M
Net Income Q3 2024 · Jun 30, 2023 −$19.15M
Net Income Q3 2024 · Mar 31, 2023 −$20.88M
Operating Income Q3 2024 · Sep 30, 2023 −$24.01M
Operating Income Q3 2024 · Sep 30, 2023 −$65.61M